Related Experiment Video
Updated: Jun 25, 2026
08:13
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
Published on: January 7, 2018
Diabetes, insulin resistance and sugars
1Centre de Recherche en Nutrition Humaine Rhône-Alpes, Univ de lyon, Lyon, France. martine.laville@chu-lyon.fr
Summary
Dietary sugars like sucrose and fructose may impact insulin resistance, but human studies show unclear links to type 2 diabetes. Fructose
Area of Science:
- Metabolic disorders and dietary influences.
Background:
- Insulin resistance is linked to type 2 diabetes, hypertension, and cardiovascular disease.
- Dietary factors contributing to these metabolic disorders remain poorly understood.
- Animal studies suggest sugars, especially sucrose and fructose, reduce insulin sensitivity and may cause hypertriglyceridemia.
Purpose of the Study:
- To review metabolic pathways implicated in sugar-induced insulin resistance.
- To evaluate the evidence linking sugar consumption to insulin resistance and diabetes in humans.
- To clarify the role of specific sugars, like fructose, in metabolic health.
Main Methods:
- Overview of metabolic pathways involved in insulin resistance.
- Systematic review of intervention, prospective, and cross-sectional studies.
- Analysis of human studies on sugar intake, insulin sensitivity, and diabetes risk.
Main Results:
- No clear relationship found between total simple carbohydrate intake and glycemic control or type 2 diabetes risk.
- Specific evidence regarding sucrose's effect on diabetes development is lacking.
- Discrepancies exist in studies on fructose's long-term impact on diabetes, but its role in lipogenesis and triglyceridemia is noted.
Conclusions:
- Current human studies do not establish a definitive link between overall simple carbohydrate intake and type 2 diabetes.
- Further research is needed to understand the specific effects of sucrose and fructose on diabetes development.
- The impact of fructose on lipogenesis and triglyceridemia warrants attention due to its widespread use in food and beverages.
Related Concept Videos
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...